International Stem Cell Corp holds annual meeting, elects four directors

International Stem Cell Corporation (the "Company") held its Annual Meeting of Stockholders on June 14, 2023. The stockholders considered two proposals, which are described in more detail in the Company's definitive proxy statement dated April 28, 2023. Proposal 1: Election of four directors to hold office until the 2024 Annual Meeting: A. Directors elected by holders of Series D Preferred Stock: FOR WITHHELD Andrey Semechkin 2,457,143 0 Russell Kern 2,457,143 0 B. Directors elected by holders of all shares of stock (including shares of preferred stock voting on an as-converted basis): FOR WITHHELD Donald A. Wright 7,833,624 44,091 Paul V. Maier 7,834,844 42,871 Broker Non-Votes: none All of the foregoing candidates were elected.